Dr. Edward Allen Levine, MD

Dr. Levine practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Levine's NPI, 1275518334, was assigned on December 13, 2005. Dr. Levine graduated from North Carolina Medical School in 1985. Dr. Levine holds North Carolina license 9801353.

Dr. Levine's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

Dr. Levine's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Levine is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levine practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Levine's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Levine is licensed in North Carolina.

CMS data shows 198 Medicare services from Dr. Levine across 6 procedure codes in 2024, for 149 Medicare patients. Medicare paid $18,473 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 149 Medicare patients who saw Dr. Levine in 2024. The largest group is 65 to 74, with 78 patients. 70% of them have cancer, and 68% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Levine's median patient age at 70, with 66% women.

In 2024, Dr. Levine wrote 42 Medicare Part D claims for 19 patients. 52% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $595 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

Dr. Levine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of mastectomy by Dr. Levine, more than 84% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 233 papers to Dr. Levine, published from 2010 to 2025. 2022 was the busiest year, with 18. The most frequent topics are Peritoneal Neoplasms, Cytoreduction Surgical Procedures and Hyperthermia, Induced. Dr. Levine has published most often in Ann Surg Oncol. Dr. Levine's most frequent co-authors are Konstantinos Ioannis Votanopoulos, MD, Perry Shen, MD and Marissa Michelle Howard-McNatt, MD.

Dmand AI links Dr. Levine to 8 clinical trials, 3 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Peritoneal Neoplasms, Abdominal Neoplasms and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 2 general payments to Dr. Levine from 2 drug and device companies in 2017. Honoraria make up the largest share, 89% of the total. Sysmex America, Inc. paid the most, $350.

Dr. Levine graduated from North Carolina Medical School in 1985.